Fig. 5From: A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronavirusesInhibition of GL25E on cell–cell fusion medicated by S protein of HCoVs. Inhibition of GL25E on cell–cell fusion mediated by S protein of SARS-CoV (a), MERS-CoV (b), HCoV-NL63 (c), HCoV-229E (d) and HCoV-OC43 (e). Each sample was tested in triplicate, and the experiment was repeated at least twice. Data from a representative experiment are presented as means ± SDBack to article page